Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma [Gastrointestinal Cancer]

Conclusion
High-dose hypofractionated proton therapy demonstrated high LC rates for HCC and ICC safely, supporting ongoing phase III trials of radiation in HCC and ICC.

Source: Journal of Clinical Oncology - February 2, 2016 Category: Cancer & Oncology Authors: Hong, Wo, Yeap, Ben-Josef, McDonnell, Blaszkowsky, Kwak, Allen, Clark, Goyal, Murphy, Javle, Wolfgang, Drapek, Arellano, Mamon, Mullen, Yoon, Tanabe, Ferrone, Ryan, DeLaney, Crane, Zhu Tags: Radiation, Radiation Oncology Gastrointestinal Cancer Source Type: research